Ultimovacs

Oslo, Norway

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

$32.3M raised

Oct 2021

Post-IPO Equity

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ultimovacs

How much funding has Ultimovacs raised?

Ultimovacs has raised $32.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2021.

Where is Ultimovacs headquartered?

Ultimovacs is headquartered in Oslo, Norway.

What does Ultimovacs do?

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

What stage is Ultimovacs at?

Ultimovacs is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 26, 2021.

MLA

"Ultimovacs — Funding & Investors." VCBacked, October 26, 2021, https://www.vcbacked.co/company/ultimovacs. Accessed July 2, 2026.

APA

VCBacked. (2021). Ultimovacs — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ultimovacs

Wikipedia (cite web)

{{cite web |title=Ultimovacs — Funding & Investors |url=https://www.vcbacked.co/company/ultimovacs |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 26, 2021.